- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Cutaneous DLBCL, Leg Type
Total 8986 results
-
Kyowa Kirin China Pharmaceutical Co., Ltd.Recruiting
-
GenmabCompletedCutaneous T-Cell LymphomaUnited Kingdom, Germany, United States, Sweden
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands
-
Medical University of ViennaRecruiting
-
Sorrento Therapeutics, Inc.RecruitingMycosis FungoidesUnited States
-
Rochester General HospitalBausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLCWithdrawn
-
OnxeoTerminatedNon-Hodgkin's Lymphoma | Cutaneous T-Cell Lymphoma | Peripheral T-Cell LymphomaUnited States, Germany, Israel, France, Thailand
-
Peter MacCallum Cancer Centre, AustraliaThe Leukemia and Lymphoma SocietyCompletedMultiple Myeloma | Cutaneous LymphomaAustralia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Advanced Malignant Solid Neoplasm | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedMelanocytic Nevi | Acquired Melanocytic Nevi | Primary Cutaneous MelanomaUnited States
-
Angimmune LLCM.D. Anderson Cancer Center; Yale University; University of Texas Southwestern... and other collaboratorsCompletedMycosis Fungoides | Sezary Syndrome | T-cell Lymphomas | T-cell Leukemia | Cutaneous T-cell Lymphoma (CTCL)United States
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Yonsei University; Korea Cancer...CompletedCutaneous T Cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-negative | Angioimmunoblastic T Cell Lymphoma | Peripheral T Cell Lymphoma UnspecifiedKorea, Republic of
-
AdventHealth Translational Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
Selcuk UniversityRecruitingTherapy-Associated Cancer | Lymphedema of Leg | Sensitisation | BalancedTurkey
-
Regeneron PharmaceuticalsCompletedAdvanced Cutaneous Squamous Cell CarcinomaUnited States, Spain, France, Italy, Australia, Germany, Brazil, Greece
-
University Hospital, GhentCompletedVenous Insufficiency of Leg | Nocturia | Edema Leg | Bio-Impedance MeasurementsBelgium
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Metastatic Merkel Cell Carcinoma | Metastatic Skin Squamous Cell Carcinoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Basal Cell Carcinoma | Unresectable Merkel Cell Carcinoma | Unresectable... and other conditionsUnited States
-
University Medical Center GroningenStichting Hemato-Oncologie voor Volwassenen NederlandRecruitingNHL | DLBCL - Diffuse Large B Cell LymphomaNetherlands
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Jiangsu Cancer Institute & HospitalUnknownDiffuse Large B-Cell Lymphoma (DLBCL)China
-
Hospital Universitario Principe de AsturiasUnknownDiffuse Large B-Cell Lymphoma (DLBCL)Spain
-
Melanoma Institute AustraliaWithdrawnMelanoma | In-Transit Metastasis of Cutaneous MelanomaAustralia
-
National Cancer Institute (NCI)TerminatedNeoplasms | Mycosis Fungoides | Cutaneous T-Cell LymphomaUnited States
-
University of MinnesotaTerminated
-
Wake Forest University Health SciencesOrthopaedic Trauma Association; Orthopaedic Research and Education FundCompletedType II and IIa Open Tibia FracturesUnited States
-
National Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | NHL | DLBCLUnited States
-
Szeged UniversityCompleted
-
Regeneron PharmaceuticalsSanofiActive, not recruitingCutaneous Squamous Cell CarcinomaUnited States, Germany, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
MacroGenicsActive, not recruitingColorectal Cancer | Advanced Cancer | Prostate Cancer Metastatic | Cutaneous Melanoma | Solid Tumor, Adult | Squamous Cell Non Small Cell Lung CancerUnited States, Spain, Bulgaria, Poland, Ukraine
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)Japan
-
Mundipharma Research LimitedActive, not recruitingMultiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell LymphomaFrance, United States, Netherlands, Spain, Switzerland, Germany, Italy
-
Genzada Pharmaceuticals USA, Inc.Translational Drug DevelopmentActive, not recruitingSarcoma | Lymphoma | Breast Cancer | Gastric Cancer | Pancreatic Cancer | Solid Tumor | Cutaneous T-cell Lymphoma | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Colo-rectal Cancer | Cutaneous T Cell Lymphoma | Prostate Cancer Metastatic | Basal Cell Carcinoma | Solid Carcinoma | Solid Carcinoma of Stomach | Cancer of Stomach and other conditionsUnited States
-
Maimónides Biomedical Research Institute of CórdobaInstituto de Salud Carlos III; Hospital Universitario Reina Sofia de CordobaRecruiting
-
LanZhou UniversityBeigene (Beijing) Biotechnology Co., LtdNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingDiffuse Large B Cell Lymphoma (DLBCL)China
-
Philogen S.p.A.Terminated
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma,DLBCLChina
-
Samsung Medical CenterCompletedDiffuse Large B-cell Lymphoma (DLBCL)Korea, Republic of
-
Novartis PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma in Situ (CSCCis)Belgium, Australia, United States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell CarcinomaUnited States
-
Polish Lymphoma Research GroupTerminatedLymphoma, T-Cell, Cutaneous | Mycosis FungoidesPoland
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore